Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population-Reference-Cited by-同舟云学术

Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population

Published:2020-08-26 Issue:14 Volume:61 Page:3331-3341
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Ghione Paola¹,Qi Shunan²³,Imber Brandon S.²,Seshan Venkatraman⁴,Moskowitz Alison¹,Galasso Natasha¹,Lunning Matthew¹,Straus David¹,Sauter Craig⁵,Dahi Parastoo⁵,Dogan Ahmet⁶,Yahalom Joachim²,Horwitz Steven¹

Affiliation:

1. Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA

2. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

3. Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

4. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

5. Department of Medicine, Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA

6. Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1811864

Reference37 articles.

1. NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018

2. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

3. Suzuki R. NK/T cell lymphoma: updates in therapy. Current hematologic malignancy reports. 2018.

4. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

5. Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. China Anti-Cancer Association (CACA) guidelines for holistic integrative management of lymphoma (version 2022);Holistic Integrative Oncology;2023-11-27

2. Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas;Haematologica;2023-11-21

3. Treatment and Prognosis of Newly Diagnosed Advanced-Stage Extranodal Natural Killer/T-Cell Lymphoma: A Single-Center Real-World Study across Two Decades;Chemotherapy;2023-11-20

4. Outcomes and prognostic factors of patients with Extranodal NK T cell lymphoma (ENKTL);Leukemia & Lymphoma;2023-08-21

5. Toxicity of a Modified PEG-Asparaginase-Based SMILE Regimen Is Comparable to L-Asparaginase-Based SMILE in a Non-Asian Population;Clinical Lymphoma Myeloma and Leukemia;2023-08